ICON Announces the Commencement of Direct Trading on NASDAQ Read more about ICON Announces the Commencement of Direct Trading on NASDAQ
ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare, Inc. Read more about ICON To Acquire Clinical Trial Services Division of Cross Country Healthcare, Inc.
Mr. Thomas Lynch Elected as Chairman of ICON plc Read more about Mr. Thomas Lynch Elected as Chairman of ICON plc
ICON shareholders vote in favour of all resolutions at its Extraordinary General Meeting relating to the proposed conversion to a direct listing of ICON's shares on NASDAQ Read more about ICON shareholders vote in favour of all resolutions at its Extraordinary General Meeting relating to the proposed conversion to a direct listing of ICON's shares on NASDAQ
ICON plc provides 2013 Financial Guidance ahead of Investor Day in New York Read more about ICON plc provides 2013 Financial Guidance ahead of Investor Day in New York
Dr. Bruce Given notifies ICON that he will not seek a further term as Chairman of the Board Read more about Dr. Bruce Given notifies ICON that he will not seek a further term as Chairman of the Board
ICON Announces Publication of EGM Circular in Respect of Proposed Conversion to Direct Listing of its Shares on NASDAQ Read more about ICON Announces Publication of EGM Circular in Respect of Proposed Conversion to Direct Listing of its Shares on NASDAQ
ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209) Read more about ICON Reports Q3 Revenue of $286 Million, EPS of 29c and Net New Business of $450 Million. (NASDAQ: ICLR) (ISIN:IE0005711209)
ICON Forms Strategic Partnership with University College Dublin Read more about ICON Forms Strategic Partnership with University College Dublin
ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209) Read more about ICON Reports second quarter 2012 revenue up 19% to $277 million and non-GAAP EPS of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)
